Condition: Stroke · Sponsor: Hospices Civils de Lyon
Cerebrovascular accident is the 2nd leading cause of death and the leading cause of disability in the world. There are brakes and levers of medication adherence in the context of secondary prevention treatment in stroke.
This description comes directly from the study's public registry record.
Teddy Novais, PharmD, PhD · +33472432155 · teddy.novais@chu-lyon.fr
Always discuss trial participation with your own doctor first.
| institute of aging - Hôpital des Charpennes | Villeurbanne, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05741593